Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « associated »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
associate < associated < association  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 116.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000001 (2020) A. Prasse [Allemagne] ; F. Bonella [Allemagne] ; U. Müller-Ladner [Allemagne] ; T. Witte [Allemagne] ; N. Hunzelmann [Allemagne] ; J. Distler [Allemagne][Treatment of systemic sclerosis-associated interstitial lung disease].
000003 (2020) Charlotte Girard-Guyonvarc'H ; Michele Iudici[Targeted therapies for connective tissue diseases and vasculitis].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000010 (2020) Aline Pfefferle [Australie] ; Nicholas D. Huntington [Australie]You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
000011 (2020) Binqing Fu ; Xiaoling Xu ; Haiming WeiWhy tocilizumab could be an effective treatment for severe COVID-19?
000017 (2020) Franziska Düver [Allemagne] ; Benedikt Wei Brich [Allemagne] ; Matthias Eyrich [Allemagne] ; Matthias Wölfl [Allemagne] ; Paul G. Schlegel [Allemagne] ; Verena Wiegering [Allemagne]Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysis
000024 (2020) Joel Hirsh ; Patrick Wood ; Angela Keniston ; Dennis Boyle ; Itziar Quinzanos ; Liron Caplan ; Lisa DavisUniversal Health Literacy Precautions Are Associated With a Significant Increase in Medication Adherence in Vulnerable Rheumatology Patients
000046 (2020) Gabriela Sanchez-Petitto [États-Unis] ; Noa G. Holtzman [États-Unis] ; Ali Bukhari [États-Unis] ; Matthew Brown [États-Unis] ; Megan K. Morales [États-Unis] ; Madhurima Koka [États-Unis] ; Jean A. Yared [États-Unis] ; Saurabh Dahiya [États-Unis] ; Aaron P. Rapoport [États-Unis] ; Nancy M. Hardy [États-Unis]Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
000048 (2020) Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000050 (2020) Daichi Fukaya [Japon] ; Tsutomu Inoue [Japon] ; Yuta Kogure [Japon] ; Hiroshi Kajiyama [Japon] ; Keisuke Ishizawa [Japon] ; Takeru Seto [Japon] ; Hajime Hasegawa [Japon] ; Toshihide Mimura [Japon] ; Hirokazu Okada [Japon]Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.
000058 (2020) Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
000062 (2020) Athimalaipet V. Ramanan [Royaume-Uni] ; Andrew D. Dick [Royaume-Uni] ; Catherine Guly [Royaume-Uni] ; Andrew Mckay [Royaume-Uni] ; Ashley P. Jones [Royaume-Uni] ; Ben Hardwick [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Matthew Smyth [Royaume-Uni] ; Thomas Jaki [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni]Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
000066 (2020) Ramya Ramaswami [États-Unis] ; Kathryn Lurain [États-Unis] ; Cody J. Peer [États-Unis] ; Anna Serqui A [États-Unis] ; Victoria Y. Wang [États-Unis] ; Anaida Widell [États-Unis] ; Priscila Goncalves [États-Unis] ; Seth M. Steinberg [États-Unis] ; Vickie Marshall [États-Unis] ; Jomy George [États-Unis] ; William D. Figg [États-Unis] ; Denise Whitby [États-Unis] ; Joseph Ziegelbauer [États-Unis] ; Thomas S. Uldrick [États-Unis] ; Robert Yarchoan [États-Unis]Tocilizumab in Patients with Symptomatic Kaposi sarcoma Herpesvirus (KSHV)- associated Multicentric Castleman disease.
000069 (2020) Hanping Wang [République populaire de Chine] ; Ran Tian [République populaire de Chine] ; Peng Gao [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Li Zhang [République populaire de Chine]Tocilizumab for Fulminant Programmed Death 1 Inhibitor-Associated Myocarditis.
000085 (2020) Ran Li ; Kunchi Zhao ; Qing Ruan ; Chunyang Meng ; Fei YinThe transcription factor Foxd3 induces spinal cord ischemia-reperfusion injury by potentiating microRNA-214-dependent inhibition of Kcnk2
000089 (2020) Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis]The paradox of cancer genes in non-malignant conditions: implications for precision medicine
000094 (2020) Ashish Sharma [Inde] ; Ashok Kumar [Inde] ; Alka Jha [Inde] ; Anunay Agarwal [Inde] ; Anoop Misra [Inde]The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis – a cross-sectional study
000101 (2020) Mohammed Shah ; Derek M. Yellon ; Sean M. DavidsonThe Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium
000107 (2020) Kyung Eun Kim ; Suwon Jeon ; Jisun Song ; Tae Sung Kim ; Min Kyung Jung ; Myun Soo Kim ; Sunyoung Park ; Seung Beom Park ; Jeong Min Park ; Hyun Jeong Park [Corée du Sud] ; Daeho ChoThe Novel Synthetic Peptide AESIS-1 Exerts a Preventive Effect on Collagen-Induced Arthritis Mouse Model via STAT3 Suppression
000109 (2020) Eric Toussirot [France]The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000110 (2020) Anna Gluba-Brz Zka ; Beata Franczyk ; Robert Olszewski ; Jacek RyszThe Influence of Inflammation on Anemia in CKD Patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "associated" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "associated" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    associated
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021